Skip to menu Skip to content Skip to footer

2026

Journal Article

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

Shah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). 582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI. Gastrointestinal Endoscopy, 103 (5), S-2414. doi: 10.1016/s0016-5107(26)05633-6

582 COMPARISON OF CULTURE OF DUODENAL ASPIRATE, GLUCOSE BREATH TEST AND GAS-SENSING CAPSULE DATA ON THE SYMPTOMATIC RESPONSE TO RIFAXIMIN IN PATIENTS WITH DGBI

2026

Journal Article

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

Fairlie, Thomas, Celine, Patricia, Shah, Ayesha, Lim, Yenkai, Morrison, Mark and Holtmann, Gerald (2026). Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION. Gastrointestinal Endoscopy, 103 (5), S-2457. doi: 10.1016/s0016-5107(26)05745-7

Su1302 IN VITRO EFFECTS OF RIFAXIMIN ON THE DUODENAL MUCOSA ASSOCIATED MICROBIOTA CULTURED FROM PATIENTS WITH OVERLAPPING DISORDERS OF GUT-BRAIN INTERACTION

2026

Journal Article

Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION

Luong, Suzanna, Wang, William J., McKillen, Ben, Moy, Naomi, Do, Anh and Holtmann, Gerald (2026). Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION. Gastroenterology, 170 (6), S-723. doi: 10.1016/s0016-5085(26)01999-2

Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION

2026

Journal Article

Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP

Shah, Ayesha, Moy, Naomi, Kulin, Dmitrii, Callaghan, Gavin, Fairlie, Thomas, Virgo, Kate, Hansen, Teressa J., Jones, Michael P., Koloski, Natasha A., Thapar, Nikhil and Holtmann, Gerald (2026). Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP. Gastrointestinal Endoscopy, 103 (5), S-1850. doi: 10.1016/s0016-5107(26)04391-9

Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP

2026

Journal Article

Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIAL

Bredenoord, Albert J., Nguyen, Nam Q., Ho, Vincent, Ko, Hin Hin, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Kolisnik, Tyler, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIAL. Gastroenterology, 170 (6), S-817. doi: 10.1016/s0016-5085(26)02201-8

Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIAL

2026

Journal Article

Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Kulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastrointestinal Endoscopy, 103 (5), S-1946. doi: 10.1016/s0016-5107(26)04599-2

Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

2026

Journal Article

Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION

Luong, Suzanna, Wang, William J., McKillen, Ben, Moy, Naomi, Do, Anh and Holtmann, Gerald (2026). Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION. Gastrointestinal Endoscopy, 103 (5), S-723. doi: 10.1016/s0016-5107(26)01930-9

Su1114 ACUTE EFFECTS OF BOTULINUM TOXIN ON THE DISTENSIBILITY OF THE LES IN PATIENTS WTIH SUSPECTED ACHALASIA AND ESOPHAGEAL OUTLET OBSTRUCTION

2026

Journal Article

Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation Disorders

Shah, Ayesha and Holtmann, Gerald (2026). Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation Disorders. Neurogastroenterology and Motility, 38 (4) e70275. doi: 10.1111/nmo.70275

Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation Disorders

2026

Journal Article

Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial

Long, Millie, Allegretti, Jessica R, Danese, Silvio, Germinaro, Matthew, Baker, Thomas, Alvarez, Yelina, Kavalam, Mary, Han, Chenglong, Jörgens, Silke, Jiang, Lingjing, Zhang, Hongyan, Hisamatsu, Tadakazu, Rubin, David T, Peyrin-Biroulet, Laurent, Abu-Farsakh, Niazy, Al-Rousan, Lawrence, An, Ping, Argollo, Marjorie, Arguelles Arias, Federico, Augustyn, Monika, Baert, Filip, Balderramo, Domingo, Banerjee, Rupa, Baum, Curtis, Bermudez Villegas, Emilio, Blanco, Antonio, Bortlik, Martin, Bouhnik, Yoram, Soledad Brunatto, Luciana ... Zou, Duowu (2026). Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology, 11 (4), 284-298. doi: 10.1016/S2468-1253(25)00322-X

Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial

2026

Journal Article

Gastrointestinal symptoms and systemic comorbidities in patients with POTS : a systematic review and meta‐analysis

Kulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Gastrointestinal symptoms and systemic comorbidities in patients with POTS : a systematic review and meta‐analysis. Neurogastroenterology & Motility, 38 (4) e70305, 1-13. doi: 10.1111/nmo.70305

Gastrointestinal symptoms and systemic comorbidities in patients with POTS : a systematic review and meta‐analysis

2026

Journal Article

Exercise capacity and neuromuscular fitness in people with disorders of gut-brain interaction (DGBI)

Bell, Katherine, Kulin, Dmitrii, McAllister, Sarah, Cougan, Rhiannon, O'Brien, Jake, West, Dale, Shah, Ayesha, Koloski, Natasha, Nicol, Jennifer, Holtmann, Gerald and Coombes, Jeff (2026). Exercise capacity and neuromuscular fitness in people with disorders of gut-brain interaction (DGBI). Journal of Clinical Exercise Physiology, 15 (s2), 225-225. doi: 10.31189/2165-7629-15-s2.225

Exercise capacity and neuromuscular fitness in people with disorders of gut-brain interaction (DGBI)

2026

Journal Article

symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interaction

Colomier, Esther, Jones, Michael P., Holvoet, Lieselot, Van den Houte, Karen, Van de Bruaene, Cedric, Broeders, Bert, Bai, Tao, Liu, Jinsong, Melchior, Chloé, Gourcerol, Guillaume, Chuah, Kee-Huat, Hui, Khoo Xin, Mahadeva, Sanjiv, Ho Siah, Kewin Tien, Lipták, Peter, Banovcin, Peter, Holtmann, Gerald, Koloski, Natasha, Carabotti, Marilia, Annibale, Bruno, Suzuki, Hidekazu, Sano, Masaya, Ueda, Takashi, Hajihashemi, Parisa, Shahoon, Hassan, Adibi, Payman, Simrén, Magnus, Gwee, Kok-Ann, Tack, Jan and Carbone, Florencia (2026). symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interaction. American Journal of Gastroenterology, Publish Ahead of Print 10.14309/ajg.0000000000003996. doi: 10.14309/ajg.0000000000003996

symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interaction

2026

Journal Article

Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol‐related harm

Palmer, Andrew J., Connor, Jason P., Holtmann, Gerald, Saunders, John B., Rice, Katie, Yeo, Jeremy, Huang, Andrea and Clark, Paul J. (2026). Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol‐related harm. Addiction, 121 (3), 472-487. doi: 10.1111/add.70208

Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol‐related harm

2026

Conference Publication

WEIGHT LOSS OUTCOMES IN RESPONSE TO TREATMENT WITH DUODENAL-JEJUNAL BYPASS LINER ARE THE SAME REGARDLESS OF DIABETES SEVERITY ASSESSED USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Idris, Iskandar, Benes, Marek, Haluzik, Martin, Byrne, James, Munro, Lynne, Frydenberg, Harry, Teare, Julian, Ruban, Aruchuna, Mason, John, Holtmann, Gerald, Mcmaster, Jess and Ryder, Robert (2026). WEIGHT LOSS OUTCOMES IN RESPONSE TO TREATMENT WITH DUODENAL-JEJUNAL BYPASS LINER ARE THE SAME REGARDLESS OF DIABETES SEVERITY ASSESSED USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE. THOUSAND OAKS: SAGE PUBLICATIONS INC.

WEIGHT LOSS OUTCOMES IN RESPONSE TO TREATMENT WITH DUODENAL-JEJUNAL BYPASS LINER ARE THE SAME REGARDLESS OF DIABETES SEVERITY ASSESSED USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

2026

Journal Article

Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward

Grady, John, Johnson, Kevin M., Kellermayer, Richard, Winter, Harland S., Tabibian, James H., Buness, Cynthia W., Fischer, Ryan, Shah, Ayesha, Dulai, Parambir S., Rangnekar, Amol S., Alrabadi, Leina, Shah, Shamita B., Holtmann, Gerald, Räisänen, Laura, Lewindon, Peter and Ali, Ahmad H. (2026). Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward. Expert Review of Gastroenterology & Hepatology, 20 (3) 17474124.2026.2635420, 233-246. doi: 10.1080/17474124.2026.2635420

Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward

2026

Journal Article

Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasia

Jacob, Ronen Ben, Fairlie, Thomas, Talley, Nicholas J., Taylor, Andrew, Frankel, Adam, Smithers, B. Mark, Pandolfino, John E., Jones, Michael P., Hourigan, Luke F., Shah, Ayesha and Holtmann, Gerald (2026). Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasia. Neurogastroenterology and Motility, 38 (1) e70223, 1-11. doi: 10.1111/nmo.70223

Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasia

2025

Journal Article

Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory study

Marinucci, Nicole, Koloski, Natasha, Baker, Kate, Moy, Naomi and Holtmann, Gerald (2025). Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory study. Australian and New Zealand Journal of Public Health, 49 (6) 100295, 100295. doi: 10.1016/j.anzjph.2025.100295

Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory study

2025

Journal Article

Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux disease

Koloski, N. A., Jones, M. P., Shah, A., Holtmann, G. and Talley, N. J. (2025). Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux disease. Neurogastroenterology and Motility, 37 (12) e70117, e70117. doi: 10.1111/nmo.70117

Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux disease

2025

Conference Publication

Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis

Malone, Amanda, Helliwell, James, Kowalski, Mark, Nguyen, Nam, Ko, Hin Hin, Holtmann, Gerald, Afif, Waqqas, Bredenoord, Albert J., Dobek, Christine, Ravikumar, Pranali, Peck, Vik and Dellon, Evan S. (2025). Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.14309/01.ajg.0001131024.83021.f2

Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis

2025

Journal Article

Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases

Moniruzzaman, Md, Shah, Ayesha, Fairlie, Thomas, Keely, Simon, Burns, Grace L., Talley, Nicholas and Holtmann, Gerald (2025). Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases. United European Gastroenterology Journal, 13 (9) ueg2.70115, 1-14. doi: 10.1002/ueg2.70115

Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases